474 related articles for article (PubMed ID: 3275777)
21. Design of potent substrate-analogue inhibitors of canine renin.
Hui KY; Siragy HM; Haber E
Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
[TBL] [Abstract][Full Text] [Related]
22. N-(alpha-Hydroxyalkanoyl) derivatives of Leu-Val-Phe-OCH3 as inhibitors of renin.
Johnson RL
J Med Chem; 1980 Jun; 23(6):666-9. PubMed ID: 6993683
[TBL] [Abstract][Full Text] [Related]
23. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of human renin. Cyclic peptide analogues containing a D-Phe-Lys-D-Trp sequence.
Dutta AS; Gormley JJ; McLachlan PF; Major JS
J Med Chem; 1990 Sep; 33(9):2560-8. PubMed ID: 2202829
[TBL] [Abstract][Full Text] [Related]
25. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
26. Pepstatin analogues as novel renin inhibitors.
Guégan R; Diaz J; Cazaubon C; Beaumont M; Carlet C; Clément J; Demarne H; Mellet M; Richaud JP; Segondy D
J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
[TBL] [Abstract][Full Text] [Related]
27. Enzymatically stable renin inhibitors containing statine and 6 aminohexanoic acid. Part IV.
Paruszewski R; Jaworski P; Tautt J; Dudkiewicz J
Boll Chim Farm; 1994 May; 133(5):301-8. PubMed ID: 8068237
[TBL] [Abstract][Full Text] [Related]
28. alpha-Methylproline-containing renin inhibitory peptides: in vivo evaluation in an anesthetized, ganglion-blocked, hog renin infused rat model.
Thaisrivongs S; Pals DT; Lawson JA; Turner SR; Harris DW
J Med Chem; 1987 Mar; 30(3):536-41. PubMed ID: 3546690
[TBL] [Abstract][Full Text] [Related]
29. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human renin by synthetic peptides derived from its prosegment.
Cumin F; Evin G; Fehrentz JA; Seyer R; Castro B; Menard J; Corvol P
J Biol Chem; 1985 Aug; 260(16):9154-7. PubMed ID: 3894354
[TBL] [Abstract][Full Text] [Related]
31. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
32. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
[TBL] [Abstract][Full Text] [Related]
33. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
[TBL] [Abstract][Full Text] [Related]
34. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
[TBL] [Abstract][Full Text] [Related]
35. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
[TBL] [Abstract][Full Text] [Related]
36. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
Paruszewski R; Tautt J; Dudkiewicz J
Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
[TBL] [Abstract][Full Text] [Related]
37. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
38. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
[TBL] [Abstract][Full Text] [Related]
39. Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal DPro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues.
Leban JJ; Landavazo A; McDermed JD; Diliberto EJ; Jansen M; Stockstill B; Kull FC
J Med Chem; 1994 Feb; 37(4):439-45. PubMed ID: 8120863
[TBL] [Abstract][Full Text] [Related]
40. alpha-Melanotropin: the minimal active sequence in the frog skin bioassay.
Hruby VJ; Wilkes BC; Hadley ME; Al-Obeidi F; Sawyer TK; Staples DJ; de Vaux AE; Dym O; Castrucci AM; Hintz MF
J Med Chem; 1987 Nov; 30(11):2126-30. PubMed ID: 2822931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
